ValiRx plc (VAL) — Net Asset Quality Index
ValiRx plc (VAL) has a Net Asset Quality Index of 97.2% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of £3.10 Million minus total liabilities of £87.45K yields net assets of £3.01 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check asset resilience ratio of ValiRx plc to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
ValiRx plc Net Asset Quality Index Over Time (2001–2024)
This chart shows how ValiRx plc's Net Asset Quality Index has evolved across 25 annual periods from 2001 to 2024. As of June 2025, the index stands at 97.2%, representing net assets of £3.01 Million against total assets of £3.10 Million GBP. See ValiRx plc (VAL) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for ValiRx plc (2001–2024)
The table below presents the year-by-year Net Asset Quality Index for ValiRx plc from 2001 to 2024, covering 25 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see ValiRx plc (VAL) market capitalisation.
| Year | Quality Index | Net Assets (GBP) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 91.9% | £3.92 Million | £4.26 Million | £346.41K | ▼ -0.9 pp |
| 2023 | 92.8% | £2.90 Million | £3.13 Million | £226.51K | ▼ -3.5 pp |
| 2022 | 96.2% | £3.83 Million | £3.98 Million | £149.65K | ▼ -0.7 pp |
| 2021 | 96.9% | £3.41 Million | £3.52 Million | £109.56K | ▲ +0.6 pp |
| 2020 | 96.3% | £4.76 Million | £4.94 Million | £182.40K | ▲ +34.6 pp |
| 2019 | 61.7% | £2.22 Million | £3.60 Million | £1.38 Million | ▼ -9.9 pp |
| 2018 | 71.6% | £3.03 Million | £4.23 Million | £1.20 Million | ▲ +7.7 pp |
| 2017 | 63.9% | £3.15 Million | £4.94 Million | £1.78 Million | ▲ +16.1 pp |
| 2016 | 47.8% | £2.37 Million | £4.96 Million | £2.59 Million | ▼ -40.8 pp |
| 2015 | 88.5% | £4.53 Million | £5.12 Million | £588.55K | ▲ +11.6 pp |
| 2014 | 77.0% | £2.79 Million | £3.62 Million | £835.08K | ▼ -1.7 pp |
| 2013 | 78.7% | £3.23 Million | £4.11 Million | £876.10K | ▼ -16.4 pp |
| 2012 | 95.1% | £5.04 Million | £5.30 Million | £261.63K | ▼ -1.8 pp |
| 2011 | 96.9% | £4.42 Million | £4.57 Million | £141.00K | ▲ +17.0 pp |
| 2010 | 79.9% | £2.00 Million | £2.50 Million | £503.00K | ▲ +25.4 pp |
| 2009 | 54.5% | £907.00K | £1.67 Million | £758.00K | ▼ -22.6 pp |
| 2008 | 77.0% | £1.37 Million | £1.78 Million | £409.00K | ▼ -17.5 pp |
| 2007 | 94.5% | £1.67 Million | £1.77 Million | £97.00K | ▼ -1.7 pp |
| 2006 | 96.2% | £2.69 Million | £2.79 Million | £105.00K | ▲ +1.5 pp |
| 2006 | 94.7% | £161.00K | £170.00K | £9.00K | ▲ +10244.7 pp |
| 2005 | -10150.0% | £-203.00K | £2.00K | £205.00K | ▼ -9821.4 pp |
| 2004 | -328.6% | £-69.00K | £21.00K | £90.00K | ▼ -381.7 pp |
| 2003 | 53.2% | £67.00K | £126.00K | £59.00K | ▲ +123.0 pp |
| 2002 | -69.8% | £-141.00K | £202.00K | £343.00K | ▼ -132.0 pp |
| 2001 | 62.2% | £1.00 Million | £1.61 Million | £609.00K | — |